(RXST)
NGM – Real vaqt narxi. Valyuta: USD
6.26
-0.23 (-3.54%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
6.26
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:34 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NGM – Real vaqt narxi. Valyuta: USD
6.26
-0.23 (-3.54%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
6.26
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 4:34 PM EDT
RxSight, Inc., tijorat bosqichidagi tibbiy texnologiyalar kompaniyasi, AQShda kataraktaning jarrohlik amaliyotida qo'llaniladigan yorug'lik bilan sozlanadigan intraokulyar linzalarni (LAL) tadqiq qilish va ishlab chiqish, ishlab chiqarish va sotish bilan shug'ullanadi. U shifokorlarga kataraktaning jarrohlik amaliyotidan keyin bemorlar uchun ko'rish o'tkirligini sozlash va yaxshilash imkonini beruvchi RxSight tizimini taklif etadi. Kompaniyaning RxSight tizimi quyidagilarni o'z ichiga oladi: RxSight Light Adjustable Lens (LAL), fotosensitiv materialdan tayyorlangan intraokulyar linza bo'lib, u ultrabinafsha nurlarning ma'lum bir naqshlariga javoban shaklini o'zgartiradi va bu ko'zning tuzatilmagan o'tkirligini yaxshilash uchun sozlanishi mumkin; va RxSight yorug'likni yetkazib beruvchi qurilma, ofisga asoslangan yorug'lik bilan davolash moslamasi bo'lib, u kataraktaning jarrohlik amaliyotidan keyin istalgan ko'rishni olish uchun zarur bo'lgan vizual tuzatish asosida LALni o'zgartirish uchun dasturlashtirilgan naqshda UV nurlarini taqdim etadi. RxSight, Inc. ilgari Calhoun Vision, Inc. nomi bilan tanilgan va 2017-yil fevral oyida RxSight, Inc. nomini olgan. Kompaniya 1997-yilda tashkil etilgan va Aliso Viejo, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ilya Goldshleger Ph.D. | Chief Operating Officer |
| Dr. Ronald M. Kurtz M.D. | President, CEO & Director |
| Mr. Adam Dashe | Executive Vice President of International |
| Mr. Eric J. Weinberg | Chief Business Development Officer |
| Mr. Mark Wilterding | Chief Financial Officer |
| Mr. Oliver Moravcevic | Vice President of Investor Relations |
| Mr. Patrick Cullen | Executive VP of Quality & Infrastructure Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-19 | 8-K/A | d115727d8ka.htm |
| 2026-01-12 | 8-K | rxst-20260111.htm |
| 2025-12-23 | 8-K | rxst-20251223.htm |
| 2025-12-22 | 8-K | d19913d8k.htm |
| 2025-12-19 | 8-K | rxst-20251218.htm |
| 2025-11-05 | 8-K | rxst-20251105.htm |
| 2025-08-15 | 8-K/A | rxst-20250731.htm |
| 2025-08-07 | 10-Q | rxst-20250630.htm |
| 2025-08-04 | 8-K | rxst-20250731.htm |
| 2025-07-08 | 8-K | rxst-20250708.htm |
| Mr. Scott Gaines |
| Chief Customer Officer |
| Ms. Maureen O'Connell | Executive VP of Clinical & Regulatory Affairs |